Toyo Seikan Group Holdings
VC Fund
Tokyo, Japan
Toyo Seikan Group Holdings is a VC fund in Tokyo focused on Biotechnology and Medical. Toyo Seikan Group Holdings, Ltd. primarily manufactures, markets, and sells metal, plastic, and glass packaging products and containers. The Company specializes in food, 18-liter, and other beverage cans. Toyo Seikan also produces steel products such as steel sheets.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Toyo Seikan Group Holdings invests in
Stages Toyo Seikan Group Holdings invests in
Countries Toyo Seikan Group Holdings invests in
Round sizes
Round size
- Seed
- $1M–$10M
- Series B
- $9.2M–$15M
Investment Focus
Industry
- Biotechnology 4 (33%)
- Medical 3 (25%)
- Food and Beverage 3 (25%)
- Health Care 2 (17%)
- Food Processing 2 (17%)
Stage
- Seed 3 (25%)
- Series B 2 (17%)
- Venture - Series Unknown 2 (17%)
- Series A 1 (8%)
- Series C 1 (8%)
Country
- Japan 5 (42%)
- Singapore 3 (25%)
- Malaysia 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Seadling is a seaweed biotech company that accelerates seaweed farming. Seadling was founded in 2018 and was headquartered in Malaysia. | $1M / Seed / Mar 03, 2025 | ||
| Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics. | $15.2M / Series B / Oct 07, 2024 | ||
| Umitron is a data company for aquaculture. We support fish farmers to increase productivity through data analytics. One of the biggest challenges in aquaculture is increasing feeding costs. We optimize feed amount and timing by using fish behavior analytics and water quality data. Our goal is to install Sustainable Aquaculture on Earth. | $9.2M / Series B / Jun 07, 2022 | ||
| DAIZ produces and sells plant-based meat, 'Miracle Meat' which uses germinated soybeans by the proprietary 'Ochiai Germination Method.' Also, DAIZ engages in research and development of raw materials, and drug discovery from germinated soybeans. | $26.1M / Series C / Feb 01, 2022 | ||
| Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system. | $9.5M / Venture - Series Unknown / Jan 06, 2022 | ||
| Shiok Meats is cellular aquaculture and cell-based meat company. With a mission to bring clean and healthy meats and seafood by harvesting from cells instead of animals. Shiok Meats brings cell-based crustacean meats that are animal-, health- and environment-friendly.Shiok Meats was founded in 2018 and is headquartered in Central Region,Singapore. | Convertible Note / Jul 21, 2021 | ||
| Shiok Meats is cellular aquaculture and cell-based meat company. With a mission to bring clean and healthy meats and seafood by harvesting from cells instead of animals. Shiok Meats brings cell-based crustacean meats that are animal-, health- and environment-friendly.Shiok Meats was founded in 2018 and is headquartered in Central Region,Singapore. | $10M / Seed / Jul 21, 2021 | ||
| Oishi kenko is a healthcare business through food as a philosophy so that everyone can eat delicious Health is a recipe search and menu creation service supervised by a registered dietitian for the purpose of preventing and managing diseases and dieting. | Venture - Series Unknown / Mar 01, 2021 | ||
| Shiok Meats is cellular aquaculture and cell-based meat company. With a mission to bring clean and healthy meats and seafood by harvesting from cells instead of animals. Shiok Meats brings cell-based crustacean meats that are animal-, health- and environment-friendly.Shiok Meats was founded in 2018 and is headquartered in Central Region,Singapore. | $12.6M / Series A / Sep 29, 2020 | ||
| iPS PORTAL focuses on contract testing of iPS cells and worked to promote the widespread use of iPS cell technology. | $839.5K / Corporate Round / Mar 27, 2015 | ||
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Toyo Seikan Group Holdings invest in?
Toyo Seikan Group Holdings invests primarily in Biotechnology, Medical and Food and Beverage startups, most often at Seed and Series B stage. Most of the 12 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Toyo Seikan Group Holdings invest in?
Toyo Seikan Group Holdings typically joins rounds of $1M–$10M at Seed and $9.2M–$15M at Series B. These are whole funding-round sizes, not Toyo Seikan Group Holdings's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Toyo Seikan Group Holdings took part in.
When did Toyo Seikan Group Holdings last invest?
The most recent investment recorded for Toyo Seikan Group Holdings closed in Mar 2025. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
